Riskpilot← Back to searchSign inGet full accessBODØ HUDLEGEKLINIKK AS
ASActiveOrg 924671408City Nord Stormyrveien 20, 8008 BodøMedical specialists activities · NACE 8622Est. 20203 employees
Revenue 2024
NOK 7,8M
+4% vs 2023
EBITDA margin
46.4%
-4% vs 2023
Equity ratio
5.3%
Financial strength
Net profit 2024
NOK 2,8M
+9% vs 2023
| Revenue | NOK 7,8M | +4% |
| EBITDA | NOK 3,6M | -4% |
| Net profit | NOK 2,8M | +9% |
| Total assets | NOK 3M | -59% |
| Equity | NOK 160K | -97% |
| Employees | 3 | — |
Legal name
BODØ HUDLEGEKLINIKK AS
Org number
924671408
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
11. mars 2020
Share capital
NOK 30 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Lege- og helsetjenester, herunder spesialistpraksis i dermatologi. Selskapet kan også investere i aksjer og andeler, samt fast eiendom.
Address
City Nord Stormyrveien 20, 8008 Bodø
Phone
+4775521100
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 982 | 4 645 | 6 529 | 7 523 | 7 843 |
| Staff expenses | −971 | −1 367 | −1 898 | −2 066 | −2 452 |
| EBITDA | 761 | 1 568 | 3 080 | 3 771 | 3 637 |
| Depreciation & amort. | −108 | −307 | −427 | −396 | −185 |
| EBIT | 653 | 1 262 | 2 652 | 3 375 | 3 452 |
| Net financials | −4 | −6 | −0 | −5 | 164 |
| Profit before tax | 649 | 1 255 | 2 652 | 3 370 | 3 615 |
| Tax | 140 | 276 | 614 | 788 | 812 |
| Net profit | 508 | 979 | 2 038 | 2 583 | 2 804 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 161 | 3 385 | 4 627 | 7 334 | 3 000 |
| Equity | 527 | 1 506 | 3 544 | 6 127 | 160 |
| Long-term debt | 12 | 11 | 0 | 0 | 0 |
| Short-term debt | 1 622 | 1 869 | 1 083 | 1 207 | 2 840 |
| Total debt | 1 634 | 1 879 | 1 083 | 1 207 | 2 840 |
EBITDA margin
46.4%
This company
15.8%
Market median
+194% vs market
20202024
Equity ratio
5.3%
This company
38.2%
Market median
-86% vs market
20202024
Return on equity
1748.7%
This company
18.4%
Market median
+9404% vs market
20202024
Net profit margin
35.7%
This company
8.1%
Market median
+341% vs market
20202024
Asset turnover
2.61×
This company
1.12×
Market median
+133% vs market
20202024
Debt / equity
17.71×
This company
0.62×
Market median
-2756% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AO Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BODØ HUDLEGEKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Adel-Reka Olasz | Chief Executive Officer | 0 companies |
| Knut Helge Frostmo Kaspersen | Board of Directors | 0 companies |